Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

2020311 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 21, Issue 10, pp. 1269-1282

Field-Weighted Citation Impact: 19.44